inflammation

Latest

inflammation

Featured Neuroscience Open Neuroscience Articles Psychology

·July 2, 2020

A Low Level of Cortisol Contributes to the Aging Process

Low levels of the stress hormone cortisol and the GLIZ protein can trigger chronic inflammatory responses in the body, contributing to the aging process. Read More

Featured Neuroscience

·June 15, 2020

Brothers in arms: The brain and its blood vessels

Blood vessels can sense the metabolic state of nearby neurons. An imbalance of fatty acids is sensed by neural blood vessels, stimulating them to mount a stress response by loosening the blood-brain barrier. If the imbalance remains, the leaky blood-brain barrier can induce a disease state. Read More

Featured Neuroscience

·June 8, 2020

Test confirms COVID-19 as trigger for rare Kawasaki-like syndrome in children

New evidence confirms COVID-19 infection is the cause of the Kawasaki-like syndrome affecting children. Read More

Autism Featured Neuroscience

·May 26, 2020

Exposure to ‘good bacteria’ during pregnancy buffers risk of autism-like syndrome

Rat study suggests prenatal microbial exposure influences neurodevelopmental outcomes. Read More

Featured Neuroscience

·May 24, 2020

Preventing ‘cytokine storm’ may ease severe COVID-19 symptoms

Treating coronavirus patients with alpha-blockers may help prevent the cytokine storm associated with severe COVID-19 infection. Alpha-blockers interfere with the cell signaling that triggers cytokine storms. Mice with bacterial infections that were treated with alpha-blockers experienced reduced cytokine storms and decreased death rates. Read More

Featured Neurology Neuroscience Psychology

·May 15, 2020

The Potential of COVID-19 to Infect the Brain

From losing the sense of taste or smell to developing an increased risk of stroke, researchers investigate both the known and potential long-term implications of COVID-19 infection in the brain. Read More

Featured Neurology Neuroscience

·May 15, 2020

Gut microbiome influences ALS outcomes

Study reveals a new gut-brain connection in amyotrophic lateral sclerosis (ALS). The gut microbiome could influence the severity of the neurodegenerative disease. Altering the bacteria in the gut may prevent or improve symptoms of ALS. Read More

Featured Neurology Neuroscience

·May 14, 2020

Local inflammatory cells are characteristic for advanced multiple sclerosis

In late-stage multiple sclerosis, inflammatory cells no longer enter the brain via the bloodstream, but instead the cells arise in memory from local memory cells inside the brain. The findings suggest during the late phases of multiple sclerosis, the disease is occurring entirely inside the brain. Read More

Featured Neuroscience Open Neuroscience Articles

·May 14, 2020

COVID-19 may be linked to rare inflammatory disorder in young children

Study describes an increase in cases of a rare Kawasaki-like disease in children infected by coronavirus. The condition causes blood vessels to become inflamed and swollen, leading to fever, rashes, red eyes, cracked lips, swollen glands, and redness on the extremities. The condition is believed to be an abnormal immune overreaction to COVID-19 infection. Read More

Featured Neuroscience

·May 13, 2020

Coronavirus infection in children – it may not start with a cough

Gastrointestinal symptoms, coupled with a fever or history of exposure to COVID-19, could indicate coronavirus infection in children. Read More

Featured Genetics Neuroscience Psychology

·May 11, 2020

Researchers pinpoint genes behind sex biases in autoimmune disorders and schizophrenia

A new study reveals why women are more likely to develop autoimmune conditions like lupus and Sjögren's syndrome, and men are more likely to develop schizophrenia. Researchers implicated the C4 gene in sex-based risk factors for autoimmune and psychiatric disorders. Read More

This shows someone holding a box of actemra

Featured Neurology Neuroscience

·May 3, 2020

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

UCSD has launched a Phase III clinical trial to assess whether tocilizumab (Actemra), a drug commonly prescribed for rheumatoid arthritis and other inflammatory disorders, has therapeutic value for those at risk of developing severe COVID-19 infection. The drug is a monoclonal antibody-based therapy that blocks receptors for interleukin-6, a cytokine that triggers inflammation as an early immune response to coronavirus. Blocking IL-6 could prevent the risk of the COVID-19 associated cytokine storm many with severe infection experience. Read More

1 2 3 … 48